{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:37:00Z","timestamp":1790627820961,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jcjo.2014.03.009","type":"journal-article","created":{"date-parts":[[2014,5,24]],"date-time":"2014-05-24T02:16:26Z","timestamp":1400897786000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada"],"prefix":"10.1016","volume":"49","author":[{"given":"Lin","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Dorrepaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2014.03.009_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF01977971","article-title":"\u00dcber die Behandlung der Netzhautabl\u00f6sung durch operative Entleerung der subretinalen Fl\u00fcssigkeit und Einspritzen vom Luft in den Glask\u00f6rper","volume":"79","author":"Ohm","year":"1911","journal-title":"Graefe Arch Klin Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib2","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mayocp.2011.10.001","article-title":"The expanding role of vascular endothelial growth factor inhibitors in ophthalmology","volume":"87","author":"Stewart","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"5 Suppl","key":"10.1016\/j.jcjo.2014.03.009_bib4","article-title":"Evolving guidelines for intravitreous injections","volume":"24","author":"Aiello","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2014.03.009_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1442-9071.2006.01231.x","article-title":"Intravitreous injections","volume":"34","author":"Bylsma","year":"2006","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0181-5512(08)75468-8","article-title":"Evolving intravitreous injection technique","volume":"31","author":"Weber","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jfo.2009.03.001","article-title":"Recommendations for carrying out intravitreal injections","volume":"32","author":"Korobelnik","year":"2009","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib8","article-title":"Steps for a safe intravitreal injection technique: a look at how European and American approaches compare","author":"Meyer","year":"2009","journal-title":"Retinal Phys."},{"key":"10.1016\/j.jcjo.2014.03.009_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/08820538.2010.541318","article-title":"Intravitreal injection technique","volume":"26","author":"Doshi","year":"2011","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/ceo.12026","article-title":"Intravitreal injections: a most recent evidence for best practice","volume":"41","author":"Fagan","year":"2013","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.eye.6702232","article-title":"National survey of the technique of intravitreal triamcinolone injection in the United Kingdom","volume":"21","author":"Anijeet","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.jcjo.2014.03.009_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajo.2010.08.039","article-title":"Survey of intravitreal injection techniques among retinal specialists in the United States","volume":"151","author":"Green-Simms","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IAE.0b013e3181ed8c80","article-title":"Bilateral intravitreal injection of antivascular endothelial growth factor therapy","volume":"31","author":"Mahajan","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2014.03.009_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajo.2009.02.013","article-title":"Bilateral simultaneous intravitreal injections in the office setting","volume":"148","author":"Bakri","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ajo.2007.12.036","article-title":"Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting","volume":"145","author":"Pilli","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration; two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/JCM.37.5.1564-1566.1999","article-title":"Abiotrophia species as a cause of endophthalmitis following cataract extraction","volume":"37","author":"Namdari","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib18","first-page":"473","article-title":"Reducing oral flora contamination of intravitreal injections with face mask or silence","volume":"32","author":"Doshi","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2014.03.009_bib19","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib20","first-page":"1446","article-title":"The effect of preop lid scrubs and levofloxacin on eyelid and conjunctival cultures prior to cataract surgery","volume":"44","author":"Bucci","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2014.03.009_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/IAE.0b013e3181eac724","article-title":"Randomized trial of anaesthetic methods for intravitreal injections","volume":"31","author":"Blaha","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2014.03.009_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/IAE.0b013e31822f27ca","article-title":"Comparison of topical anesthetics for intravitreal injections: a randomized clinical trial","volume":"32","author":"Davis","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2014.03.009_bib23","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0161-6420(02)01236-8","article-title":"Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery","volume":"109","author":"Ta","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib24","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ophtha.2009.02.024","article-title":"A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal","volume":"116","author":"Moss","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archophthalmol.2009.304","article-title":"Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network laser-ranibizumabtriamcinolone clinical trials","volume":"127","author":"Bhavsar","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.ophtha.2010.12.014","article-title":"Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections","volume":"118","author":"Kim","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib27","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.ophtha.2010.03.034","article-title":"Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections","volume":"117","author":"Kim","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib28","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in Antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection","volume":"119","author":"Milder","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9394(02)01332-6","article-title":"Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS","volume":"133","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/IAE.0b013e3181a94f01","article-title":"Intravitreal injection of therapeutic agents","volume":"29","author":"Peyman","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2014.03.009_bib31","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajo.2004.01.028","article-title":"Vitreous wick syndrome\u2014a potential cause of endophthalmitis after intravitreal injection of triamcinolone through the pars plana","volume":"137","author":"Chen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib32","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ajo.2008.07.007","article-title":"Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents","volume":"146","author":"Kim","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.eye.6702938","article-title":"Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab","volume":"23","author":"Bakri","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.jcjo.2014.03.009_bib34","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ophtha.2005.10.061","article-title":"Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide","volume":"113","author":"Benz","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3129\/i07-172","article-title":"Short-term intraocular pressure changes after intravitreal injection of bevacizumab","volume":"42","author":"Hollands","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib36","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/IAE.0b013e3180592ba6","article-title":"Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin)","volume":"27","author":"Falkenstein","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2014.03.009_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","article-title":"A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO study","volume":"148","author":"Lalwani","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib38","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial","volume":"119","author":"Chakravarthy","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib39","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2014.03.009_bib40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration [ANCHOR study 1-year data]","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcjo.2014.03.009_bib41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE Study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib42","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","article-title":"Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study)","volume":"33","author":"Massin","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjo.2014.03.009_bib43","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2010.08.016","article-title":"Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study","volume":"117","author":"Nguyen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib45","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","article-title":"Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib46","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","article-title":"Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study","volume":"118","author":"Brown","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2014.03.009_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3129\/i10-121","article-title":"Practice patterns of Canadian Ophthalmological Society members in cataract surgery\u20142010 survey","volume":"46","author":"Ong-Tone","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2014.03.009_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jcjo.2011.05.013","article-title":"Practice patterns of Canadian vitreoretinal specialists in diabetic macular edema treatment","volume":"46","author":"Schweitzer","year":"2011","journal-title":"Can J Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418214000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418214000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:03:22Z","timestamp":1757793802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418214000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0008418214000854"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2014.03.009","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2014.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}